Globe Newswire
DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- Calvetti Ferguson, a Top 200 accounting firm, welcomes a new advisory managing director to its advisory practice, elevating its turnaround, bankruptcy, and restructuring services.
Jamie Chronister brings a wealth of experience to the firm, with over 25 years of providing turnaround, bankruptcy and restructuring, and advisory support to clients. He specializes in serving clients across diverse industries, such as manufacturing,... (continue reading...)
DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- Calvetti Ferguson, a Top 200 accounting firm, welcomes a new advisory managing director to its advisory practice, elevating its turnaround, bankruptcy, and restructuring services.
Jamie Chronister brings a wealth of experience to the firm, with over 25 years of providing turnaround, bankruptcy and restructuring, and advisory support to clients. He specializes in serving clients across diverse industries, such as manufacturing,... (continue reading...)
Company announcement – No. 28 / 2024
Zealand Pharma major shareholder announcement: Polar Capital
Copenhagen, Denmark, 29 May 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt on 24 May 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following... (continue reading...)
GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences:
- Jefferies Global Healthcare Conference (New York, NY)Wednesday, June 5, 2024Fireside Chat at 2:00 p.m. Eastern Time
- Goldman Sachs Global Healthcare Conference (Miami Beach, FL)Wednesday,... (continue reading...)
Company announcement number 41/2024
Result of auction of mortgage covered bonds (SDRO’s) in series 11F, 12E and 12F
Today, Realkredit Danmark has completed the auctions of mortgage covered bonds (SDRO’s) in series 11F, 12E and 12F for the refinancing of FlexKort®, RD Cibor6® Green and RD Cibor6® as of 1 July 2024.
... (continue reading...)More Globe Newswire
View Older Stories-
FTI Consulting Appoints Michael Spadea as North America Leader for Information Governance, Privacy and Security
-
Else Nutrition Adds New, Ready-to-Drink Kids Shakes at Canada’s Largest Grocery Chain
-
Stardust Power Announces Further Key Management Appointments
-
CORRECTION – CTO Realty Growth Declares Dividends For the Second Quarter 2024 (Ex-Dividend Date Correction)
-
Lotus Technology Reinforces ESG Commitment to its "Driving Change" Vision through 2023 Annual Report
-
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2024
-
Golconda Gold Ltd. Releases Financial and Operating Results for Q1 2024
-
Pasinex Provides Update on Status of Turkish Legal Matters
-
CORRECTION – Alpine Income Property Trust Declares Dividend For the Second Quarter 2024 (Ex-Dividend Date Correction)
-
Abercrombie & Fitch Co. Reports First Quarter Fiscal 2024 Results
-
Kura Oncology to Participate in Jefferies Global Healthcare Conference
-
Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
-
Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
-
Lotus Technology Reinforces ESG Commitment to its "Driving Change" Vision through 2023 Annual Report
-
Buckley Capital Management Urges Dentalcorp Holdings Board and Management to Undertake a Strategic Review Process
-
Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting
-
Abercrombie & Fitch Co. Reports First Quarter Fiscal 2024 Results
-
LeddarTech Announces Participation in the Maxim Group Virtual TMT Conference on June 4, 2024 and the Deutsche Bank Global Auto Industry Conference on June 11-12, 2024 in New York, NY
-
Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
-
Streamline Health® Announces New RevID™ Contract with 400-Bed Health System
-
Arbutus to Participate in Jefferies Global Healthcare Conference
-
Vyluma Announces Marketing Authorization Application Validation for the European Union
-
Invesco Ltd: Form 8.3 - International Paper Company
-
Howard Hughes Holdings Inc. to Present at NAREIT REITweek 2024 Investor Conference
-
Red Pine Intercepts Significant Mineralization at the Wawa Gold Project, including 5.58 g/t gold over 18.44 m including 72.20 g/t gold over 0.88 m
-
Draganfly to Present at Centurion One Los Angeles Summit 2024
-
Ocugen to Present at BIO International Convention 2024
-
The Habit Burger Grill Opens Second Lancaster Location in Home State of California
-
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
-
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
-
Gildan Activewear Reports on Shareholders’ Voting Results
-
Sable Stakes Additional Ground Along the Perk Rocky Regional Trend in BC, Canada
-
Valore Update of Hatchet Lake Uranium Project
-
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
-
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
-
Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
-
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
-
ProKidney to Participate in the Jefferies Global Healthcare Conference
-
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
-
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
-
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
Plum Teams Up with hireEZ to Improve Recruiting Outcomes Through Job Matching
-
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
-
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
-
Plymouth Industrial REIT to Present at Nareit’s REITweek 2024
-
Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
-
Bitfarms Responds to Unsolicited Proposal from Riot Platforms
-
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases